|
WO2016115092A1
|
|
Methods for targeting host vascular mechanism for therapeutic protection against hemorrhagic fever
|
|
WO2016090035A2
|
|
Modulators of activin and methods for modulating immune responses and t follicular helper cells
|
|
WO2015077434A2
|
|
Pan pollen immunogens and methods and uses thereof for immune response modulation
|
|
WO2015077442A2
|
|
Grass pollen immunogens and methods and uses thereof for immune response modulation
|
|
WO2015054231A1
|
|
Methods and uses for identifying responders to allergy therapy
|
|
WO2015054217A2
|
|
Methods and uses for reducing an allergic response in a subject
|
|
WO2014183062A1
|
|
Autoimmune disease treatments
|
|
WO2014153424A1
|
|
Reducing diabetes in patients receiving hmg-coa reductase inhibitors (statins)
|
|
US2015110819A1
|
|
T cell epitopes from cockroach and methods of making and using same
|
|
AU2013203359A1
|
|
Antagonistic human LIGHT-specific human monoclonal antibodies
|
|
WO2013119863A1
|
|
Timothy grass allergens and methods and uses for immune response modulation
|
|
WO2013119853A1
|
|
Epitopes from allergen proteins and methods and uses for immune response modulation
|
|
EP2723372A2
|
|
Protection against dengue virus and prevention of severe dengue disease
|
|
WO2012177788A1
|
|
Modulators of 4-1bb and immune responses
|
|
EP2720705A2
|
|
Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseases
|
|
WO2011163628A2
|
|
Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof
|
|
WO2011127288A2
|
|
Methods and uses of nur77 and nur77 agonists
|
|
WO2011123697A2
|
|
Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammation
|
|
EP2531859A2
|
|
Compositions and methods of modulating receptor protein tyrosine phosphatases
|
|
EP2566878A1
|
|
Methods of inhibiting inflammation and inflammatory diseases using gal-3bp (btbd17b, lgals3bp, galectin-3 binding protein, mac-2 binding protein)
|
